Astro-Med, Inc. (Astronova) 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report on Form 10-Q for Astro-Med, Inc. (referred to as Astronova in metadata, but Astro-Med in the filing) for the period ended October 31, 2009. The company is a manufacturer of specialty high-tech printing systems, electronic medical instrumentation, and test and measurement instruments. It operates through three segments: Test & Measurement (T&M), QuickLabel Systems, and Grass Technologies (GT). The company is classified as a smaller reporting company.
Key Financial Metrics
| Metric | Three Months Ended Oct 31, 2009 | Nine Months Ended Oct 31, 2009 |
|---|---|---|
| Net Sales | $16.66 million | $47.75 million |
| Gross Profit | $7.06 million (42.4% margin) | $19.82 million (41.5% margin) |
| Operating Income | $0.96 million (5.8% margin) | $1.39 million (2.9% margin) |
| Net Income | $0.68 million | $1.04 million |
| Diluted EPS | $0.09 | $0.14 |
| Cash & Equivalents | $14.32 million | $14.32 million (Balance Sheet) |
| Total Assets | $62.57 million | $62.57 million |
| Total Liabilities | $10.10 million | $10.10 million |
| Operating Cash Flow (9mo) | $3.47 million |
Liquidity & Debt: The company holds $14.32 million in cash and cash equivalents and $9.62 million in securities available for sale. There is no long-term debt reported on the balance sheet. The company maintains a $3.5 million revolving bank line of credit, which is currently fully available.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 5.8% in the quarter and 15.0% for the nine-month period compared to the prior year, driven by the global recession and reduced capital equipment purchases.
- Profitability Pressure: Operating income dropped 11.8% in the quarter and 67.8% for the nine-month period. Operating margins contracted from 6.2% to 5.8% (quarter) and 7.7% to 2.9% (nine months) due to lower sales volume.
- Cost Reductions: Operating expenses decreased 7.0% in the quarter and 8.8% for the nine months, reflecting a company-wide cost reduction initiative including wage freezes and layoffs.
- Segment Performance:
- T&M: Sales down 10.5% (quarter) and 10.6% (nine months); profit margin declined significantly.
- QuickLabel: Sales down 5.4% (quarter) and 17.7% (nine months); hardware sales declined, though consumable supplies (Vivo! & Zeo!) grew.
- Grass Technologies: Sales down 2.2% (quarter) and 13.1% (nine months); however, segment operating profit increased 8.8% in the quarter due to expense reductions.
- Investment Portfolio: The company holds $901,450 in auction rate securities (Level 3 assets) with an unrealized loss of $98,550, which management deems temporary.
Outlook, Risks, and Unusual Items
- Outlook: Management expects to finance operations through internal funds. They continue to invest in R&D (7.0% of sales in the quarter) to drive future growth despite the economic downturn.
- Legal Proceedings: The company won a non-compete lawsuit against a former employee and new employer, with a judgment of over $1.1 million affirmed by the First Circuit Court of Appeals on October 22, 2009. The company has not recognized this gain until realized.
- Tax Benefit: A subsequent event noted a letter from the IRS concluding examinations for fiscal years 2005-2008, resulting in an expected tax benefit of approximately $335,000 to be recorded in the fourth quarter.
- Risks: Key risks include the global recession, declining demand in defense/aerospace markets, foreign currency exchange rate fluctuations, and the liquidity of auction rate securities.
Investor Verification Checklist
- Auction Rate Securities: Verify the current market status and liquidity of the $901,450 in auction rate securities, as these are Level 3 assets with no active market.
- Legal Recovery: Monitor the collection status of the $1.1 million judgment from the non-compete lawsuit.
- Backlog Trends: Note that backlog decreased 22.5% to $4.97 million; verify if this trend continues into the fourth quarter.
- Inventory Management: Confirm that inventory days on hand (106 days) remain stable as the company attempts to reduce working capital.
- Tax Provision: Verify the recording of the $335,000 tax benefit in the upcoming Q4 filing.